학술논문
POSB125 The Impact of Discounting on the Cost Effectiveness of Tisagenlecleucel for Relapsed/Refractory Acute Lymphoblastic Leukaemia
Document Type
Abstract
Author
Source
In Value in Health January 2022 25(1) Supplement:S85-S86
Subject
Language
ISSN
1098-3015